Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients
Open Access
Abstract
Increasing testing is key to achieving hepatitis C elimination. This retrospective study aimed to assess the testing cascade of patients at a regional hospital in Victoria, Australia, who inject drugs or are living with hepatitis C, to identify missed opportunities for hepatitis C care. Adult hospital inpatients and emergency department (ED) attendees from 2018 to 2021 with indications for intravenous drug use (IDU) or hepatitis C on their discharge or ED summary were included. Data sources: hospital admissions, pathology, hospital pharmacy, and outpatients. We assessed progression through the testing cascade and performed logistic regression analysis for predictors of hepatitis C care, including testing and treatment. Of 79,923 adults admitted, 1345 (1.7%) had IDU-coded separations and 628 (0.8%) had hepatitis C-coded separations (N = 1892). Hepatitis C virus (HCV) status at the end of the study was unknown for 1569 (82.9%). ED admissions were associated with increased odds of not providing hepatitis C care (odds ratio 3.29, 95% confidence interval 2.42–4.48). More than 2% of inpatients at our hospital have an indication for testing, however, most are not being tested despite their hospital contact. As we work toward HCV elimination in our region, we need to incorporate testing and linkage strategies within hospital departments with a higher prevalence of people at risk of infection.Keywords
This publication has 33 references indexed in Scilit:
- Opportunistic Treatment of Hepatitis C Infection Among Hospitalized People Who Inject Drugs (OPPORTUNI-C): A Stepped Wedge Cluster Randomized TrialClinical Infectious Diseases, 2023
- Global reporting of progress towards elimination of hepatitis B and hepatitis CThe Lancet Gastroenterology & Hepatology, 2023
- Real-world clinical effectiveness and sustainability of universal bloodborne virus testing in an urban emergency department in the UKScientific Reports, 2022
- Ten steps to eliminating hepatitis C in hospitalsNature Reviews Gastroenterology & Hepatology, 2022
- Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2022
- Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage StudyClinical Infectious Diseases, 2021
- Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C TreatmentDigestive Diseases and Sciences, 2021
- Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapyJHEP Reports, 2021
- Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in AustraliaApplied Health Economics and Health Policy, 2018
- Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascadeInternational Journal of Drug Policy, 2017